SCHEMBL7097648

SCHEMBL7097648

CC(=NO)c1ccc(O)c(O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.48
GFER P55789 2/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
MAPT P10636 5/20 0.47
CYP2C19 P33261 2/20 0.47
RAB9A P51151 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
KDM4E B2RXH2 5/20 0.46
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
GAA P10253 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
CA4 P22748 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13927323 1.00 POLB (0.48) POLBGFERCASP3SENP8SENP7
SCHEMBL14330300 1.00 POLB (0.48) POLBGFERCASP3SENP8SENP7
SCHEMBL17548939 0.83 RAB9A (0.48) POLBGFERCASP3SENP8SENP7
SCHEMBL18214939 0.81 MGLL (0.59) POLBGFERCASP3SENP8SENP7
SCHEMBL18214938 0.81 MGLL (0.59) POLBGFERCASP3SENP8SENP7
SCHEMBL4257370 0.79 KDM1A (0.66) POLBGFERMAPTRAB9ACYP1A2
SCHEMBL4257368 0.79 KDM1A (0.66) POLBGFERMAPTRAB9ACYP1A2
SCHEMBL17548941 0.78 GAA (0.63) POLBGFERMAPTRAB9ACYP1A2
SCHEMBL13268873 0.78 GAA (0.63) POLBGFERMAPTRAB9ACYP1A2
SCHEMBL12360950 0.77 CA9 (0.52) POLBGFERCASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112725849-A Environment-friendly cyanide-free alkaline galvanizing electroplating solution and preparation method and electroplating process thereof 杭州佳兴镀锌有限公司 2021-04-30 CN claimed
US-20030049287-A1 Catechol oximes and their use in cosmetic and dermatological preparations HAARMANN & REIMER GMBH (DE) 2003-03-13 US claimed
CN-112725849-A Environment-friendly cyanide-free alkaline galvanizing electroplating solution and preparation method and electroplating process thereof 杭州佳兴镀锌有限公司 2021-04-30 CN disclosed
CN-1409626-A Catechol oximes and their use in cosmetic and dermatological preparations HAARMANN & REIMER GMBH (DE) 2003-04-09 CN disclosed
US-20030049287-A1 Catechol oximes and their use in cosmetic and dermatological preparations HAARMANN & REIMER GMBH (DE) 2003-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030049287-A1 Catechol oximes and their use in cosmetic and dermatological preparations TYR, LPO, COMT POLB 483/4885GFER 285/4885CASP3 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.